MCRB vs MKTX · rev $1.1M vs P/E 13, rev $451.8M
Seres Therapeutics Inc (MCRB) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
Latest reported MKTX revenue for 2026-06-30 was $451.8M. Net income was $146.0M. Revenue was up 93.6% from 2026-03-31 to 2026-06-30. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
MCRB currently screens at market cap $109.8M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the MCRB and MKTX stock pages for the full models.
Not investment advice.